Coherus Oncology, Inc. (CHRS)

Coherus Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	103.35	125.99	102.89	63.55	417.2	541.16
Short-Term Investments	88.31	-	14.86	128.13	-	-
Cash & Short-Term Investments	191.66	125.99	117.75	191.68	417.2	541.16
Cash Growth	96.19%	7.00%	-38.57%	-54.05%	-22.91%	204.59%
Accounts Receivable	9.25	111.32	260.52	109.96	123.02	157.05
Other Receivables	241.25	11.01	-	-	-	-
Receivables	250.5	122.33	260.52	109.96	123.02	157.05
Inventory	2.05	70.09	62.61	38.79	37.64	44.23
Prepaid Expenses	16.75	23.17	34.76	40.8	24.46	25.04
Total Current Assets	460.96	341.58	475.63	381.23	602.32	767.48
Property, Plant & Equipment	1.63	7.36	11.03	14.44	16.01	10.11
Goodwill	-	-	0.94	0.94	0.9	0.94
Other Intangible Assets	49.48	53.65	70.73	4.99	2.66	2.62
Other Long-Term Assets	4.45	45.95	71.27	79.24	57.44	60.5
Total Assets	516.52	448.53	629.6	480.85	679.33	841.65
Accounts Payable	24.89	28.46	35.22	11.53	16.16	15.2
Accrued Expenses	91.71	227.04	291.11	122.85	145.68	127.32
Current Portion of Long-Term Debt	-	1.15	-	-	-	-
Current Portion of Leases	1.79	1.69	2.15	4.32	3.49	3.13
Other Current Liabilities	253.91	24.65	3.3	-	-	-
Total Current Liabilities	372.3	282.98	331.77	138.69	165.33	145.65
Long-Term Debt	50.58	292.52	473.37	471.06	408.28	404.02
Long-Term Leases	1.95	3.29	5.33	5.05	7.25	9.95
Long-Term Deferred Tax Liabilities	1.1	1.1	1.1	-	-	-
Other Long-Term Liabilities	2.82	0.63	11.46	3.47	0.75	1.05
Total Liabilities	428.75	580.52	823.03	618.27	581.61	560.68
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,433	1,419	1,386	1,204	1,148	1,044
Retained Earnings	-1,345	-1,551	-1,580	-1,342	-1,050	-762.75
Comprehensive Income & Other	-0.2	-0.28	-0.25	-0.25	-0.27	-0.27
Total Common Equity	87.77	-131.99	-193.43	-137.42	97.73	280.97
Shareholders' Equity	87.77	-131.99	-193.43	-137.42	97.73	280.97
Total Liabilities & Equity	516.52	448.53	629.6	480.85	679.33	841.65
Total Debt	54.32	298.65	480.84	480.42	419.02	417.1
Net Cash (Debt)	137.34	-172.66	-363.09	-288.74	-1.83	124.06
Net Cash Per Share	1.18	-1.50	-3.86	-3.72	-0.02	1.49
Filing Date Shares Outstanding	120.87	115.9	112.71	79.61	77.28	72.79
Total Common Shares Outstanding	116.24	115.61	112.22	78.85	76.93	72.51
Working Capital	88.66	58.6	143.86	242.54	437	621.83
Book Value Per Share	0.76	-1.14	-1.72	-1.74	1.27	3.87
Tangible Book Value	38.29	-185.64	-265.1	-143.35	94.16	277.41
Tangible Book Value Per Share	0.33	-1.61	-2.36	-1.82	1.22	3.83
Machinery	15.22	18.07	17.73	17.39	16.04	18.57
Construction In Progress	-	-	-	0.7	0.39	0.31
Leasehold Improvements	5.75	5.75	5.75	6.2	5.94	5.83

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q